- Home
- ELOX vs TLPH Comparison
ELOX vs TLPH Comparison
Compare ELOX & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELOX | TLPH |
|---|---|---|
| Founded | 1999 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.3M | 70.3M |
| IPO Year | 2013 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ELOX | TLPH |
|---|---|---|
| Price | $15.31 | $1.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $38.25 | $3.13 |
| AVG Volume (30 Days) | 21.4K | ★ 103.1K |
| Earning Date | 08-12-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,151,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.00 | $0.69 |
| 52 Week High | $23.40 | $1.57 |
Technical Indicators
Market Signals| Indicator | ELOX | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 44.16 | 40.32 |
| Support Level | $13.92 | $1.11 |
| Resistance Level | $19.43 | $1.29 |
| Average True Range (ATR) | 1.39 | 0.03 |
| MACD | -0.19 | -0.00 |
| Stochastic Oscillator | 23.89 | 4.55 |
Price Performance
Historical ComparisonAbout ELOX Eloxx Pharmaceuticals Inc. Common Stock
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.